Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
NEWTON, Mass., April 24, 2017 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that it is commencing a registered underwritten public offering of $40 million in shares of its common …